April 30, 2020
Orphan Reach today announced that regulatory approval has been obtained for Vicore Pharma’s Phase II clinical trial with VP01 (C21) in patients with COVID-19, SARS CoV-2 […]
April 1, 2020
Orphan Reach is extremely honoured to be part of this crucial Phase II COVID-19 trial at the forefront of clinical research. We are delighted to be […]
October 31, 2019
We are delighted to be exhibiting at World Orphan Drug Congress, Barcelona in less than two weeks’ time. The conference agenda covers the strategic and commercial […]
October 18, 2019
We are pleased to confirm that Orphan Reach will be attending Outsourcing in Clinical Trials Nordics next week. Meet our Client Relationship Manager, who will be […]